JNJ

238.34

-0.13%↓

UNH

275.18

+0.24%↑

TMO

547.45

+1.67%↑

ABT

111.8

+1.4%↑

ISRG

498.29

+2.04%↑

JNJ

238.34

-0.13%↓

UNH

275.18

+0.24%↑

TMO

547.45

+1.67%↑

ABT

111.8

+1.4%↑

ISRG

498.29

+2.04%↑

JNJ

238.34

-0.13%↓

UNH

275.18

+0.24%↑

TMO

547.45

+1.67%↑

ABT

111.8

+1.4%↑

ISRG

498.29

+2.04%↑

JNJ

238.34

-0.13%↓

UNH

275.18

+0.24%↑

TMO

547.45

+1.67%↑

ABT

111.8

+1.4%↑

ISRG

498.29

+2.04%↑

JNJ

238.34

-0.13%↓

UNH

275.18

+0.24%↑

TMO

547.45

+1.67%↑

ABT

111.8

+1.4%↑

ISRG

498.29

+2.04%↑

Teleflex Inc

Отворен

СекторЗдравеопазване

107.04 1.99

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

103.97

Максимум

107.18

Ключови измерители

By Trading Economics

Приходи

-531M

-409M

Продажби

132M

913M

P/E

Средно за сектора

28.636

84.243

Дивидентна доходност

1.3

Марж на печалбата

-44.785

Служители

14,100

EBITDA

-546M

-323M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+20.06% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.30%

2.28%

Следващи печалби

26.02.2026 г.

Следваща дата на дивидент

16.03.2026 г.

Следваща дата на екс-дивидент

6.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-861M

4.6B

Предишно отваряне

105.05

Предишно затваряне

107.04

Настроения в новините

By Acuity

57%

43%

284 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

Teleflex Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.02.2026 г., 17:25 ч. UTC

Придобивния, сливания и поглъщания

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9.02.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Falls on Possible Technical Correction -- Market Talk

9.02.2026 г., 23:14 ч. UTC

Пазарно говорене

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9.02.2026 г., 22:29 ч. UTC

Пазарно говорене

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9.02.2026 г., 22:19 ч. UTC

Пазарно говорене

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9.02.2026 г., 22:08 ч. UTC

Пазарно говорене

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9.02.2026 г., 22:01 ч. UTC

Печалби

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9.02.2026 г., 21:59 ч. UTC

Печалби

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9.02.2026 г., 21:59 ч. UTC

Печалби

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9.02.2026 г., 21:58 ч. UTC

Печалби

Friedman Industries 3Q Sales $168M >FRD

9.02.2026 г., 21:50 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Financial Services Roundup: Market Talk

9.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.02.2026 г., 21:48 ч. UTC

Печалби

Friedman Industries 3Q EPS 43c >FRD

9.02.2026 г., 21:17 ч. UTC

Печалби

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9.02.2026 г., 21:13 ч. UTC

Пазарно говорене

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9.02.2026 г., 21:04 ч. UTC

Печалби

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9.02.2026 г., 20:30 ч. UTC

Пазарно говорене

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9.02.2026 г., 20:02 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9.02.2026 г., 19:42 ч. UTC

Пазарно говорене

Japan's Yield Curve Expected to Flatten -- Market Talk

9.02.2026 г., 19:31 ч. UTC

Пазарно говорене

Nike Seen Regaining Relevance With Consumers -- Market Talk

9.02.2026 г., 19:27 ч. UTC

Пазарно говорене

Gold Climbs Back Over $5,000/oz -- Market Talk

9.02.2026 г., 19:05 ч. UTC

Пазарно говорене

Nike Returns to List of Hottest Brands -- Market Talk

9.02.2026 г., 18:19 ч. UTC

Пазарно говорене

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9.02.2026 г., 17:41 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9.02.2026 г., 17:31 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9.02.2026 г., 17:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Financial Services Roundup: Market Talk

9.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.02.2026 г., 17:17 ч. UTC

Пазарно говорене

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9.02.2026 г., 17:16 ч. UTC

Печалби

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Teleflex Inc Прогноза

Ценова цел

By TipRanks

20.06% нагоре

12-месечна прогноза

Среден 130.17 USD  20.06%

Висок 155 USD

Нисък 115 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Teleflex Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

7 ratings

2

Купи

4

Задържане

1

Продай

Техническа оценка

By Trading Central

122.73 / 135.75Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

284 / 352 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat